Clearside Biomedical (NASDAQ: CLSD)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting CLSD to rise to within 12 months (a possible 151.57% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $1.59 last updated August 12, 2022, 8:00 PM UTC.
The next Clearside Biomedical (CLSD) dividend date is projected to be Thursday, September 1, 2022.
Clearside Biomedical’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.